Category Archives: Faculty Recruitment

Geneticist Joe Gleeson joins faculty as professor

Joseph Gleeson, a neurogeneticist who uses genetic sequencing to identify the causes of pediatric brain disease across its spectrum, including epilepsy, autism, intellectual disability and structural disorders, has joined Rockefeller as a professor and established the Laboratory of Pediatric Brain Diseases. Dr. Gleeson, formerly a professor at the University of California, San Diego, is one of two mid-career scientists who joined the university this summer (the other, Jue Chen, was featured in the June 13 issue of BenchMarks).

Structural biologist, focused on cell transport machinery, to join faculty

Jue Chen, a structural biologist whose research focuses on transporter proteins that act as the cell’s pumping machinery, will join Rockefeller as professor and head of laboratory in July. Dr. Chen, currently a tenured professor of biology at Purdue University in Indiana, is especially interested in the role of transporter proteins in health and disease.

New faculty member studies ribosome structure

Sebastian Klinge, named to Rockefeller’s faculty in June as its newest tenure-track member, is a biochemist and structural biologist interested in understanding the ribosome, the cell’s protein factory. Dr. Klinge’s laboratory, the Laboratory of Protein and Nucleic Acid Chemistry, opened on September 15. Dr. Klinge is the first junior faculty member to be recruited under the university’s nine-year strategic plan approved in 2012, and the first faculty member of any rank to join the university since Vanessa Ruta opened her laboratory in 2011.

Neuroscientist Mary Hynes named research associate professor

Marc Tessier-Lavigne’s arrival at Rockefeller means the addition of not one, but two active neuroscience research programs to campus. This summer, Mary Hynes — Dr. Tessier-Lavigne’s wife and a well regarded neuroscientist in her own right — will relocate from Stanford. As research associate professor, she will investigate the development of the key cells targeted by Parkinson’s disease: dopaminergic neurons.